1. Registering for the Forum

    We require a human profile pic upon registration on this forum.

    After registration is submitted, you will receive a confirmation email, which should contain a link to confirm your intent to register for the forum. At this point, you will not yet be registered on the forum.

    Our Support staff will manually approve your account within 24 hours, and you will get a notification. This is to prevent the many spam account signups which we receive on a daily basis.

    If you have any problems completing this registration, please email support@jackkruse.com and we will assist you.

Low Cortisol Levels

Discussion in 'Optimal Labs' started by Eddie Garza, Apr 29, 2015.

  1. JanSz

    JanSz Gold


    The Redox Rx: How to Improve Your Redox Potential

    1. How do I test or measure my redox potential?
    2. How do I improve my redox potential?
    3. How is the redox potential described in summary?

      1. Loss of libido, erectile power,
      10. Your cortisol/melatonin saliva tests are keys to assessing the redox potential.
      12. Your hemoglobin and hematocrit, called an H/H level, can tell you if you have a lowered redox potential (you do if you are anemic).

      1. Pay attention to sunsets and dim light at night.
    Last edited: Aug 31, 2017
  2. drezy

    drezy New Member

    [quote="JanSz, post: 222694, member: 933"
    1. 1. Loss of libido, erectile power, [/quote]
    There's my favorite "lab" and towel hanger.
    Christine_L likes this.
  3. JanSz

    JanSz Gold

  4. JanSz

    JanSz Gold




    Dr Gundry's Protocol

    [qu ote="Huck, post: 222807, member: 1100"]I got mine from 23and me. I'm APOE3/4. That's the main reason I have Dr Bredesen's book on order - The End of Alzheimer's: The First
    Program to Prevent and Reverse Cognitive Decline.

    Info on Dr Gundry's plan as it relates to APOE4 - https://www.apoe4.info/wiki/Dr_Gundry's_Protocol[/quote]

    Last edited: Sep 5, 2017
  5. JanSz

    JanSz Gold


    [qu ote="Jack Kruse, post: 223025, member: 1031"]Little things are the big things in life, and it's those things that makes us ill and kill us too soon.

    Why? It ruins our................Timing.


    Time does not pass, it is created by light too, and it continues to be our precious illusion. Seize your day, but then let it go. Remember, time is also a drug, because it is built by light. Too much of it, at the wrong time kills you, eventually.

    Physics gridlocks when it takes on ontology, and people ask what's "physically" real. That question has no answer, because "physical" has no real definition; its meaning is relative, not absolute. A water molecule seems very physical; a photon in a double slit experiment, less so. It was already clear to people like Bohr that what "exists" is what's experienced, and we simply have no concepts extending beyond that. And Einstein understood that time, the present, is a property of a conscious observer because it requires a brain to create time from light. But we seem to have decided not to accept this reality, and to instead demand to know whether this or that version of the multiverse is "real". Try this thought experiment: there's another universe next door, with no life in it. What time is it over there?[/quote]

    Time does not pass, it is created by light too, and it continues to be our precious illusion.

    Time -- is --- our --- illusion.

    On the beginning there was LIGHT.
    Nothing else only LIGHT.
    No mass, no time, only LIGHT.
    LIGHT contains everything, mass, time, magnetism, everything else.
    Last edited: Sep 7, 2017
    seanb4 likes this.
  6. JanSz

    JanSz Gold

    No offense to anyone,
    it make sense (to me) to elevate #4 and make it #1

    And God said, Let there be light: and there was light.

    Wonder if there were discussions on this topic in any studies.

    Genesis 1King James Version (KJV)

    1 In the beginning God created the heaven and the earth.

    2 And the earth was without form, and void; and darkness was upon the face of the deep. And the Spirit of God moved upon the face of the waters.

    3 And God said, Let there be light: and there was light.

    4 And God saw the light, that it was good: and God divided the light from the darkness.

    5 And God called the light Day, and the darkness he called Night. And the evening and the morning were the first day.
    Last edited: Sep 10, 2017
  7. JanSz

    JanSz Gold

    page 100

    Antagonistic pleiotropy
    genetic alteration enhances fitness early in life at the expense of longevity.

    ApoE4 was first
    ApoE3 came latter (220000 years ago)(most people today, including me both copies)
    ApoE2 came (80000 years ago)

    two ApoE3--->(5% chance of Alzheimer's)
    single ApoE4--->(30% chance of Alzheimer's)
    double ApoE4--->(50% chance of Alzheimer's)

    Thank you @Huck


    The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline Hardcover – August 22, 2017

    Tell tale markers
    C-reactive protein, increase
    albumin/globulin ratio, decrease
    interleukin-6, increase
    tumor necrosis factor, increase
    metabolic or hormonal abnormalities, (insulin resistance)

    Inflammatory (type) Alzheimer's (Type 1) responds quickly to corrections (using Re-CODE) protocol.

    Type 2 atrophic (cold), most often double ApoE4

    no evidence of inflammation
    low hormones, thyroid, adrenal, estrogen, progesterone, testosterone, pregnenolone
    low vit D
    insulin either too high or too low
    homocysteine high (but it may also be high in type 1)

    This type responds to treatment more slowly than type 1


    Alzheimer's is a program of downsizing.

    Type 3 is toxic (vile) (page 105)
    tends to occur in ApoE3
    strikes at early age, 40's
    often following great stress
    this type was the reason for development of more sophisticated ReCODE.
    often very low zinc and high copper
    triglycerides low when comparing to cholesterol level

    inflammation (type 1)
    loss of trophic support (type 2)
    exposure to toxic compounds (type 3)

    Last edited: Sep 10, 2017
  8. Total EMFSolutions

    Total EMFSolutions New Member

    4 am wake up time is typically when the smart meters dump data. Your symptoms sound identical to radiowave sickness and you have alot in common with these folks. http://emfsafetynetwork.org/smart-meters/smart-meter-health-complaints/
  9. JanSz

    JanSz Gold

  10. JanSz

    JanSz Gold






    NeuroQuant Volumetric MRI

    NeuroQuant segments and measures volumes of the hippocampus, ventricles and other brain structures and compares the volumes to norms, based on the patient’s age, gender and intracranial volume. This information helps providers assess neurological conditions and neurodegenerative diseases such as:

    • Alzheimer’s disease
    • Epilepsy
    • Traumatic brain injury
    • Multiple Sclerosis

    For the patient, a NeuroQuant exam can be included as part of routine a brain MRI exam. It is an additional analysis that is added to the brain MRI exam and performed without the use of a contrast dye or ionizing radiation. The technologist performing the scan sends the data to the NeuroQuant system which identifies and segments multiple brain structures.

    The software then measures the volumes of the structures and compares the information to the normative database. Once measurements are complete, NeuroQuant generates a unique report, giving the radiologist and your medical provider more visual and quantitative information in addition to your regular MRI scan findings.



    Neuroreader™ Volumetric Brain Assessment Software




    Last edited: Sep 14, 2017
  11. JanSz

    JanSz Gold

  12. JanSz

    JanSz Gold

  13. JanSz

    JanSz Gold

  14. JanSz

    JanSz Gold


    Non-invasive, urine-based prostate cancer test available in the Netherlands from November 2015



    Pobierz przykładowy raport z badania SelectMDx Liquid Biopsy

    sample report


    Dla kogo przeznaczona jest płynna biopsja prostaty?

    Płynna biopsja prostaty – SelectMDx Liquid Biopsy przeznaczona jest dla mężczyzn z podwyższonym stężeniem PSA zainteresowanych profilaktyką raka prostaty. Badanie pozwala określić ryzyko wykrycia istotnego klinicznie raka stercza w biopsji gruczołu krokowego. Pozwala to zadecydować o zasadności wykonania tej procedury.

    Prosimy o kontakt z Urologami HIFU CLINIC Centrum Leczenia Raka Prostaty przez bezpłatną konsultację online, aby dowiedzieć się czy Twoja historia medyczna pozwala na przeprowadzenie badania.
    Last edited: Sep 30, 2017
  15. JanSz

    JanSz Gold


    Liquid Biopsy Markets, 2017-2020

    News provided by

    Research and Markets
    Sep 28, 2017, 09:00 ET

    Share this article

    DUBLIN, September 28, 2017 /PRNewswire/ --

    The "Liquid Biopsy Markets by Lung, Breast, Colorectal, Prostate and Other. 2017-2020 Including Screening Market Potential Size with Executive and Consultant Guides" report has been added to Research and Markets' offering.

    The Diagnostic, Monitoring and Screening Test opportunities are explored.

    A revolution in cancer diagnostics is occurring using in vitro blood testing to identify cancer DNA. The technology creates new markets for cancer screening tests.

    GRAIL, a new company with impressive backing, has announced a single blood test to detect all cancers. The technology is moving faster than the market. New technology that definitively identifies disease conditions from blood samples is poised to replace expensive invasive surgical biopsy procedures. The market is still in its infancy but has outstanding growth potential. The impact on the health care industry is enormous. The report forecasts the market size out to 2020. In addition, the report looks at potential market sizes by country, by cancer and by the three different opportunities: detection, management and screening.

    Use independent research that makes you the expert. Get our research team working for you by ordering this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. Get an extra player on your team as unlimited assistance and breakout data is included with your purchase.

    Circulating Tumor Cells? Cell Free DNA? Exosomes? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.

    The report includes detailed breakouts for 15 Countries and 4 Regions along with breakouts for Lung, Breast, Colorectal, Prostate and Other Cancers.

    What is the size of the huge screening opportunity? They are all listed in Chapter 10.

    All report data is available in Excel format on request.

    Make investment decisions and valuations with confidence using the latest data.

    Key Topics Covered:

    i. Liquid Biopsy Market - Strategic Situation Analysis
    ii. Guide for Executives, Marketing, Sales and Business Development Staff
    iii. Guide for Management Consultants and Investment Advisors

    1. Introduction and Market Definition
    1.1 What is Liquid Biopsy?
    1.2 The Sequencing Revolution
    1.3 Market Definition
    1.3.1 Volumes
    1.3.2 Prices
    1.3.3 Revenue Market Size
    1.4 Methodology
    1.4.1 Authors
    1.4.2 Sources
    1.5 A Spending Perspective on Liquid Biopsy
    1.5.1 An Historical Look at Clinical Testing

    2. Market Overview
    2.1 Players in a Dynamic Market
    2.1.1 Academic Research Lab
    2.1.2 Diagnostic Test Developer
    2.1.3 Genomic Instrumentation Supplier Cell Separation and Viewing Instrumentation Supplier
    2.1.4 Pharmaceutical/Reagent Supplier
    2.1.5 Independent Testing Lab
    2.1.6 Public National/regional lab
    2.1.7 Hospital lab
    2.1.8 Physician Lab
    2.1.9 Audit Body
    2.1.10 Certification Body
    2.2 Using Biopsies
    2.2.1 Cancer
    2.2.2 Precancerous conditions
    2.2.3 Inflammatory conditions
    2.3 Biopsy Sites
    2.4 The Situation Today - Biopsy Analysis
    2.5 Evidence of Cancer - Liquid Biopsy Technology
    2.5.1 The Big Picture on Liquid Biopsy Technology
    2.5.2 The Role of CTCs Types of CTCs CellSearch Detection- Ultimate Sensitivity Epic Sciences Detection- Imaging Takes the Lead Maintrac Detection - The Microscope Other Methods
    2.5.3 ctDNA - Going Mainstream?
    2.5.4 Exosomes and Micro Vesicles - New Kid on Block
    2.6 Cancer Treatment Protocol Under Siege
    2.6.1 Issues and Limitations to Liquid Biopsy Adoption - Double Diagnostics
    2.6.2 The Cancer Screening Market Opportunity GRAIL - What Is It?
    2.6.3 Cancer Management vs. Diagnosis The Role of Risk Assessment Managing Therapy Monitoring Disease - What Is It?
    2.6.4 Phases of Adoption - Looking Into The Future
    2.6.5 The Promise of Liquid Biopsy
    2.7 Structure of Industry Plays a Part
    2.7.1 Hospital Testing Share
    2.7.2 Economies of Scale Hospital vs. Central Lab
    2.7.3 Physician Office Lab's
    2.7.4 Physician's and POCT
    2.8 Profiles of Key Players
    2.8.1 Qiagen
    2.8.2 Agena Bioscience
    2.8.3 Angle plc
    2.8.4 ApoCell
    2.8.5 Biocept
    2.8.6 BioFluidica
    2.8.7 Bio-Rad Laboratories
    2.8.8 Boreal Genomics
    2.8.10 Chronix Biomedical
    2.8.11 Clearbridge BioMedics
    2.8.12 Cynvenio
    2.8.13 Cytolumina Technologies Corp
    2.8.14 CytoTrack
    2.8.15 Diagnologix LLC
    2.8.16 Epic Sciences
    2.8.17 Exosome Diagnostics
    2.8.18 Exosome Sciences
    2.8.19 Fluidigm Corp
    2.8.20 Fluxion Biosciences
    2.8.21 Genomic Health
    2.8.39 GRAIL
    2.8.22 Guardant Health
    2.8.23 HansaBiomed
    2.8.23 Horizon Discovery
    2.8.24 iCellate
    2.8.25 Illumina
    2.8.26 Inivata
    2.8.27 Janssen Diagnostics
    2.8.28 Molecular MD
    2.8.29 Myriad Genetics
    2.8.30 Natera
    2.8.31 New Oncology
    2.8.32 Personal Genome Diagnostics
    2.8.33 RainDance Technologies
    2.8.34 Rarecells SAS
    2.8.35 Silicon Biosystems
    2.8.36 Sysmex Inostics
    2.8.37 SRI International
    2.8.38 Trovagene
    2.8.39 Freenome

    3. Market Trends
    3.1 Factors Driving Growth
    3.1.1 Non Invasive Game Changer
    3.1.2 Lower Cost
    3.1.3 Greater Accuracy.
    3.1.4 Wide Range of Potential Uses
    3.1.5 Aging Population
    3.2 Factors Limiting Growth
    3.2.1 Lower prices
    3.2.2 Lack of Standards.
    3.2.3 Protocol Resistance.
    3.2.4 Initial Adoption Has No Cost Savings
    3.3 Instrumentation and Automation
    3.3.1 Instruments Key to Market Share
    3.3.2 Bioinformatics Plays a Role.
    3.4 Diagnostic Technology Development
    3.4.1 Next Generation Sequencing Fuels a Revolution
    3.4.2 Impact of NGS on pricing
    3.4.3 Pharmacogenomics Blurs Diagnosis and Treatment
    3.4.4 CGES Testing, A Brave New World
    3.4.5 Biochips/Giant magneto resistance based assay

    4. Liquid Biopsy Recent Developments
    4.1 Recent Developments - Importance and How to Use This Section
    4.1.1 Importance of These Developments
    4.1.2 How to Use This Section
    4.2 Illumina Forms GRAIL to Enable Early Cancer Detection via Liquid Biopsy
    4.3 ASCO: Researchers Present Advances, Ongoing Challenges in Liquid Biopsy
    4.4 Guardant Health, SWOG Partner on Prospective NSCLC Liquid Biopsy Study
    4.5 Qiagen Expands CDx Deal with Tokai; Acquires CTC Assets from AdnaGen
    4.6 Biodesix's GeneStrat Liquid Biopsy Lung Cancer Test
    4.7 Baylor, TGen Collaborate on Personalized Cancer Treatment Options
    4.8 Liquid Biopsy Firm Resolution Bio Gets CLIA Certification for Lab
    4.9 Broad Institute Lands $10M Gift to Study Cancer Drug Resistance
    4.10 Biocept Q1 Revenues Rise With Test Volume Growth
    4.11 CRUK Manchester Institute Joins European Consortium Validating Blood-based Cancer Biomarkers
    4.12 New Oncology Closes Financing Round to Promote Genetic Testing from Blood
    4.13 Cynvenio to present new clinical data
    4.14 EKF, Angle Collaborate for Liquid Biopsy Development
    4.15 Trovagene Collaborates with UCSD for EGFR Monitoring in Lung Cancer
    4.16 AstraZeneca Initiates CDx Partnerships with Roche, Qiagen
    4.17 Horizon, LGC Awarded Research Grant for Cancer Diagnostics
    4.18 Merck Serono and Sysmex Inostics Announce Testing Center
    4.19 Agena Bioscience Launches Smaller Format MassArray
    4.20 Personal Genome Diagnostics Aims for FDA Clearance
    4.21 HTG Molecular Diagnostics Files for IPO of up to $60M
    4.22 Genomic Health Reports 5 Percent Revenue Growth in Third Quarter
    4.23 Biocept, Rosetta Genomics Partner to Profile microRNAs from CTCs
    4.24 Inivata Raises $6.6M to Develop ctDNA Assays
    4.25 Epic Sciences Raises $30M in Private Financing
    4.26 New Release in Line of Liquid Biopsy CLIA Tests
    4.27 Collaborators Publish Data on Resolution Bio Liquid Biopsy Test
    4.27 Trovagene's Urine-Based Liquid Biopsy Platform Demonstrated in Field
    4.28 FDA Sends Pathway Genomics Untitled Letter Over Liquid Biopsy Test
    4.29 DNA in blood can track cancer development, response in real time
    4.30 Cynvenio Clinical Trial Supports Multi-Template Liquid Biopsy Sequencing
    4.31 Startup AccuraGen to Tap China Liquid Biopsy Market With 61-Gene Assay
    4.32 Sysmex Corporation and Clearbridge BioMedics to Jointly Develop New Liquid Biopsy System
    4.33 MDxHealth Launches SelectMDx "Liquid Biopsy" Test in the United States
    4.34 GATC Biotech's Liquid Biopsy Testing Takes Cost Lead
    4.35 Liquid Biotech USA, Inc. Announces Completion of Clinical Study
    4.36 Liquid biopsies more effective in some cases than tissue biopsies
    4.37 Cancer Genetics, Inc. and ApoCell Announce Partnership for Rare Cell Capture and Detection
    4.38 Exosome Diagnostics Launches Liquid Biopsy Test to Rule Out High-Grade Prostate Cancer
    4.39 Liquid Biopsy Tests Partially Validated
    4.40 FDA Approves Liquid Biopsy
    4.41 Liquid Biopsy Predicts Colon Cancer Recurrence
    4.42 WaveSense Receives CE-IVD Mark for Cell Enrichment Platform
    4.43 For Liquid Biopsy, Size Matters
    4.44 Liquid biopsy startup Freenome lands $5.5 million led by Andreessen Horowitz
    4.45 Trovagene, USC Collaborate on Deployment of Urine-Based Liquid Biopsy Test
    4.46 Circulogene liquid biopsy detects new tumor mass earlier than current imaging methods
    4.47 Clinical Utility of Biocept's Liquid Biopsy Platform Demonstrated in Study Results Presented at the 2016 San Antonio Breast Cancer Symposium
    4.48 Trovagene to Focus More on Liquid Biopsy Testing Market
    4.49 Pancreatic Cancer Gets Prognostic Tool from Liquid Biopsy
    4.50 New Start-up to Work on Scalpel-free Liquid Biopsies
    4.51 RareCyte announces $30M round
    4.52 Liquid Biopsies May Never Replace Tissue Biopsies
    4.53 Karius reels in $50M to ramp up infectious disease liquid biopsy
    4.54 Liquid Biopsy Passes Test for Nasopharyngeal Cancer
    4.55 Exosome Diagnostics Launches the MedOncAlyzer Pan-Cancer Panel
    4.56 Lonza Acquires HansaBioMed, Invests in Exosomics
    4.57 Controversial Test Highlights Precision Medicine Marketing, Regulatory Issues
    4.58 Trovagene Announces Agreement with Global Biopharmaceutical Company

    5. Country Market Sizes - North America

    6. Country Markets - Europe

    7. Country Markets - Asia Pacific

    8. Country Markets - Latin America, Africa & The Middle East

    9. Global Market Summary

    10. Potential Market Opportunity Size

    For more information about this report visit https://www.researchandmarkets.com/research/53h68b/liquid_biopsy

    Media Contact:

    Laura Wood, Senior Manager

    For E.S.T Office Hours Call +1-917-300-0470
    For U.S./CAN Toll Free Call +1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900

    U.S. Fax: 646-607-1907
    Fax (outside U.S.): +353-1-481-1716
  16. JanSz

    JanSz Gold

  17. JanSz

    JanSz Gold

    How to eat this?
    There is plenty of this in my local Indian store, including some variety.

  18. JanSz

    JanSz Gold


    [qu ote="Jack Kruse, post: 225300, member: 1031"]What is cool about bringing old science to new eyes by putting windex on the glass eyes of medicine?

    Your certificates, degrees, status and wallet do not matter. How you treat your equals and people under neath your direction matter most. Doctors and patients have the same deficits these days = They are both chronically disconnected from circadian biology and nature.

    If I can get one in hundred to see it I am doing OK.

    We see the world as what we carry in our own hearts. They see a mistake, I observe a lesson. They sees a shadow, I observe a light that casts it.
    They see the night, I observe the moon and its effect on the Earth's tilt.
    They see a corporation, I observe people who make it thrive. They see millennials as a problem, I observe our bright future. They see success, I observe the coming journey. They see me as a stranger. I observe them, as my future friend and cohort in mito-hacking for a better world.

    Where others see nothing or impossible strings.........I observe answers.

    The right thing isn't always real obvious to the rest of the world. Sometimes the right thing for one person is the wrong thing for someone else. And everything, in retrospect, is obvious to those who use forethought. How you think makes you great. 99.9% of humans use hindsight to dictate their actions. Some of us train to observe the unseen first. Ignore what the eye sees and focus on what the brain observes

    Like most things in life, everything is great— until it isn’t. #bluelight and #nnEMF reality.

    The irony of modern society is that we are now the best informed society that has ever walked this planet, but yet we also carry greatest risk of dying from our own ignorance.
    Technology allows for escapism from nature.

    This is why good people can make tragic errors for people who follow them. Case in point below.

    How does a half truth about food lead to a full lie in reality?
    The LCHF folks say this: Increase fructose load increases uric acid which inhibits production of nitric oxide constricting blood vessels to brain. pic.twitter.com/SgYMDTvij4 But they forget about the reality of the entire picture chichis this: Fructose shows up in foods that only grow in strong photosynthetic environments naturally. So fructose is never designed to be present without solar exposure. It just so happens sunlight increases NO production to offset the loss in the food with fructose. So it is really a lack of sunlight and not the foodstuff that is the real problem. #LCHFdownunder fail. #Fettkefail


    Take a look at the Nobel Prize for physics in 2016 and consider what we gave the Nobel Prize for medicine in 2017 on 10/1?

    The same thing and nobody really recognizes the convergence of science.


    There is no food we can't eat, but the other side of that coin is just because you can eat is at this particular time, doesn't mean you should do it. Humans might have survived from this flexibility, but optimal diet is not basic survival when you divorce circadian biology from photosynthetic process.

    Sun Moon Earth = Solar Eclipse

    Sun Earth Moon = Lunar Eclipse

    Moon Sun Earth = Apocalypse

    This simple verse shows you how important the location and tilt of the moon is for the Earth’s tilt and control of circadian cycles that control life on Earth.[/quote]
    Last edited: Oct 9, 2017
    Jude likes this.
  19. Jack Kruse

    Jack Kruse Administrator

    JanSz likes this.
  20. Jack Kruse

    Jack Kruse Administrator

    ^^^^that is why sunlight is a vaccine for mitochondrial diseases.
    JanSz likes this.

Share This Page